EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Akoya Biosciences, Inc. (AKYA) had EBIT Margin of -59.68% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$96.63M |
|
$-63.32M |
|
$40.33M |
|
$56.30M |
|
$154.30M |
|
$-57.67M |
|
$-5.62M |
|
$-63.28M |
|
$-63.28M |
|
$-63.32M |
|
$-63.32M |
|
$-63.32M |
|
$-63.32M |
|
$-57.67M |
|
$-48.78M |
|
44.44M |
|
44.44M |
|
$-1.43 |
|
$-1.43 |
|
| Balance Sheet Financials | |
$121.79M |
|
$10.73M |
|
$58.58M |
|
$180.37M |
|
$35.34M |
|
$76.02M |
|
$91.25M |
|
$126.60M |
|
$53.77M |
|
$18.10M |
|
$53.77M |
|
49.12M |
|
| Cash Flow Statement Financials | |
$-50.90M |
|
$3.35M |
|
$56.84M |
|
$74.53M |
|
$83.82M |
|
$9.29M |
|
$10.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.45 |
|
-- |
|
-- |
|
0.59 |
|
1.43 |
|
58.27% |
|
-59.68% |
|
|
EBIT Margin |
-59.68% |
-50.48% |
|
-65.49% |
|
-65.53% |
|
$-54.55M |
|
-- |
|
-- |
|
-- |
|
0.54 |
|
2.26 |
|
5.69 |
|
64.19 |
|
-117.77% |
|
-349.93% |
|
-35.11% |
|
-48.79% |
|
$1.09 |
|
$-1.23 |
|
$-1.15 |
|